Concourse Financial Group Securities, Inc. Evotec Se Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
16 transactions
Others Institutions Holding EVO
# of Institutions
38Shares Held
3.86MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.21MShares$3.71 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT1.11MShares$3.43 Million2.33% of portfolio
-
Morgan Stanley New York, NY385KShares$1.19 Million0.0% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA300KShares$924,8530.0% of portfolio
-
Pitcairn CO Jenkintown, PA261KShares$804,4370.07% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.09B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...